Bhubaneswar, August 31
Preparations are underway at a hospital right here for the graduation of the second section of human medical trial of ‘Covaxin’, India’s indigenous COVID-19 vaccine, officers mentioned.
“The Phase I of the trial is still continuing as we are planning for the start of the Phase II trial shortly,” mentioned Dr E Venkata Rao, Principal Investigator of the trial at Institute of Medical Sciences and SUM Hospital, college of medical sciences.
The blood samples collected from the volunteers who acquired the vaccine have been to establish how efficient the vaccine was by way of the extent of antibodies developed, Dr Rao mentioned, including that there had been “no side effects” within the first section trial of the vaccine.
The IMS and SUM Hospital is likely one of the 12 medical centres within the nation chosen by the Indian Council for Medical Research (ICMR) for conducting the human trial of the vaccine developed by Hyderabad-based Bharat Biotech.
“Two doses of the vaccine were administered to each volunteer after they were selected through a screening process conducted over a period of three to seven days prior to vaccination. The first dose was administered on Day Zero while the blood sample was collected. The second dose was given on Day 14 and the blood sample was also collected,” mentioned Dr Rao.
Blood samples of the volunteers may even be collected on completely different days (28th, 42nd, 104th and 194th day) for estimating the period of safety subsequently, he added.
Dr Rao mentioned there was a whole lot of enthusiasm amongst individuals to be a part of the second section of the human trial.
Those who want to be a part of this trial may contact the centre at http://ptctu.soa.ac.in, he mentioned. PTI